Rotarix vaccine launched in Korea

Published: 2008-07-11 07:00:00
Updated: 2008-07-11 07:00:00
GlaxoSmithKline (GSK) says it has launched Rotarix vaccine in Korea, representing the concrete step for GSK in providing a safe and effective vaccine to prevent rotavirus in this country.

Rotarix is an oral, two-dose, live attenuated vaccine developed from a single human strain designed to pro...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.